BIO-key International Inc. (NASDAQ:BKYI) Stock Short Interest Report for October

BIO-key International Inc. (NASDAQ:BKYI) saw a significant drop in short interest in the month of October. As of October 15th, there was short interest totaling 386,470 shares, a drop of 61.2% from the September 30th total of 995,329 shares. Currently, 19.8% of the shares of the stock are sold short. Based on an average trading volume of 7,692,228 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analyst Weigh In

A number of research firms recently commented on BKYI. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research report on Thursday, October 15th. Wall Street Zen raised BIO-key International to a “hold” rating in a report on Saturday, October 24th. Finally, Zacks Research raised shares of BIO-key International to a “hold” rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce”.

BIO-key International Stock Down 11.8%

Shares of NASDAQ:BKYI traded down $0.34 during midday trading on Friday, reaching $2.58. 242,851 shares of the company were exchanged, compared to its average volume of 1,783,314. The firm has a market cap of $5.26 million, a PE ratio of -0.63 and a beta of 0.50. BIO-key International has a fifty-two week low of $1.55 and a fifty-two week high of $13.80. The stock has a fifty day simple moving average of $2.59 and a two-hundred day simple moving average of $4.58.

BIO-key International (NASDAQ:BKYI) last released its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.82) by $0.26. The firm had revenue of $1.92 million for the quarter, compared to the consensus estimate of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. As a group, analysts forecast that BIO-key International will post -1.62 earnings per share for the current year.

About BIO-key International

BIO-key International, Inc (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords.

Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.